Digital Twins: The Future of Drug Discovery with Dr. Tomáš Helikar
BioTalk Unzipped16 Des 2024

Digital Twins: The Future of Drug Discovery with Dr. Tomáš Helikar

BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe engage with Dr. Tomas Helikar in an exciting discussion on the future of AI, digital twins, and personalized medicine. From mathematical models and immune system simulations to groundbreaking collaborations with the Department of Defense, this episode uncovers how digital twins have the potential to transform drug discovery and clinical trials. Don’t miss insights on the ethical challenges of data privacy, the promise of animal digital twins, and the latest AI breakthroughs like MIT’s Sparrow algorithm!

Chapters

01:00 How the mathematical models work. Normalization and Scaling in Computational Biology

07:55 Focus on the Immune System and Organ Models

09:05 Collaboration with the Department of Defense

11:03 Drug Discovery and Digital Twins

13:43 NEW NEWS! - AI in Drug Discovery: The MIT Sparrow Algorithm

17:51 Future of Digital Twins in Clinical Trials

18:59 Personalized Medicine and Individualized Treatments

23:33 The Potential of Animal Digital Twins

24:59 Building a Research Infrastructure for Digital Twins

26:03 Privacy and Ownership of Digital Twin Data

30:14 Encouraging Publication and Literature Engagement

How to reach us:

Tomas Helikar

https://www.linkedin.com/in/tomashelikar/

X - https://x.com/tomashelikar

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com /

Sound Bites

"Publications are the currency in academia."

New News Story:


Image Credits


Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(47)

Is AI Changing Scientists? The Future of Pharma with Dr. Rob Dodge

Is AI Changing Scientists? The Future of Pharma with Dr. Rob Dodge

Rob Dodge says AI has made him an expert Python programmer, even though he never took a class in it. But does having new capabilities change what it means to be a scientist?Dr. Chad Briscoe sits down ...

2 Okt 35min

Do Clinical Trials Take Too Much Blood? Patient-Centric Sampling with Joleen White

Do Clinical Trials Take Too Much Blood? Patient-Centric Sampling with Joleen White

Clinical trials often collect far more blood than an assay actually needs. Dr. Joleen White asks a more disciplined question: What information is required to make a sound decision, and how little samp...

11 Sep 48min

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Jul 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Jun 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mar 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
rss-skravla-gar
rss-pa-konto
finansredaksjonen
livet-pa-veien-med-jan-erik-larssen
lederpodden
pengepodden-2
pengesnakk
utbytte
liberal-halvtime
okonomiamatorene
rss-orjasater
morgenkaffen-med-finansavisen
tid-er-penger-en-podcast-med-peter-warren
rss-markedspuls-2
stormkast-med-valebrokk-stordalen